Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/2012
03/14/2012CN102370811A Drug for treating hordeolum
03/14/2012CN102370803A Traditional Chinese medicinal preparation for treating ocular vertigo
03/14/2012CN102370732A Drug for treating blepharitis
03/14/2012CN102370717A Medicine for treating conjunctivitis
03/14/2012CN102370711A Meridian activating massage Chinese medicinal preparation and preparation method thereof
03/14/2012CN102370710A Medicament for treating otitis media and preparation method thereof
03/14/2012CN102370709A Medicament for treating trachoma
03/14/2012CN102370698A Medicine composition for treating conjunctivitis and preparation method thereof
03/14/2012CN102370671A Active fraction in lucid ganoderma fruiting body, extracting method, application thereof and preparation
03/14/2012CN102370658A Eyedrops for treating presbyopia and preparation method thereof
03/14/2012CN102370628A Tetra-acetylated puerarin self-microemulsified sustained-release double-layer tablet and preparation method thereof
03/14/2012CN102370617A Ophthalmic huperzine A microemulsion and preparation method thereof
03/14/2012CN102370395A Chinese medicinal health-care pillow and manufacturing method thereof
03/14/2012CN102028694B Application of Fasudil in preparing medicaments for treating glaucoma through ophthalmic drug delivery
03/14/2012CN101422595B Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof
03/14/2012CN101313982B Traditional Chinese medicine onion slurry, preparing method and uses thereof
03/13/2012US8133890 Glaucoma and/or ocular hypertension; stability; lower dosage
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012CA2543452C Therapeutic agent for keratoconjunctival disorder
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/08/2012WO2012031123A2 Method of treating ear infections
03/08/2012WO2012030918A1 Adenosine a3 receptor modulating compounds and methods of use thereof
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029160A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution
03/08/2012WO2012028585A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012WO2011122872A3 Composition comprising coumestrol or a bean extract containing coumestrol
03/08/2012WO2011100489A3 Improved live bacterial vaccine safety
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059067 1-acetyl-5-hydroxyanthracene-9,10-dione for treatment of retinal disease
03/08/2012US20120059060 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
03/08/2012US20120059052 Prenylflavonoid formulations
03/08/2012US20120059049 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059034 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058983 Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058964 Pharmaceutical formulation
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058934 Treatment of diseases
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058206 Antiallergic marine biopolymers
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058187 Water-in-oil type emulsion for treating a disease of the eye
03/08/2012US20120058161 Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof
03/08/2012US20120058155 Slow-degrading polymers for undelayed and sustained drug delivery
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058099 Use of hypoxanthine for promotion of neuronal outgrowth
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058088 Resveratrol-Containing Compositions And Methods Of Use
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012CA2809700A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2424842A2 Dual mechanism inhibitors for the treatment of disease
03/07/2012EP2424836A2 A process for isolation of lutein and zeaxanthin crystals from plant sources
03/07/2012EP2424546A1 Method of reducing intraocular pressure in humans
03/07/2012EP2424542A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
03/07/2012EP2424535A2 Methods and compositions for treating dry eye
03/07/2012EP2424502A1 Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
03/07/2012EP2424495A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
03/07/2012EP2424494A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
03/07/2012EP2424360A1 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1390036B1 Prostanoic acid derivatives as agents for lowering intraocular pressure
03/07/2012EP1009388B1 Sustained release drug delivery devices
03/07/2012CN102366561A Chinese herbal medicine for treating acute and chronic dacryocystitis
03/07/2012CN102366551A Chinese herbal medicine for treating dacryostenosis and lacrimal duct obstruction
03/07/2012CN102366528A Chinese herbal medicine for treating blepharitis
03/07/2012CN102366526A Propolis health care liquid
03/07/2012CN102366488A Chinese herbal medicine for treating infectious conjunctivitis
03/07/2012CN102366400A Betahistine hydrochloride injection and its production technology
03/07/2012CN102366398A Multifunctional eye drops
03/07/2012CN102145126B Pharmaceutical composition for treating xerophthalmia
03/07/2012CN102010454B Citicoline sodium compound and new method thereof
03/07/2012CN101816627B Synergistic treatment type multi-material sustained-release eye drop and preparation method
03/07/2012CN101185687B Fumigation and cleaning medicine for treating acute conjunctivitis
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129431 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
03/06/2012US8129405 Quinuclidine derivatives and medicinal compositions containing the same
03/06/2012CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/06/2012CA2468664C Ketorolac tromethamine compositions for treating or preventing ocular pain
03/06/2012CA2452881C Novel bicyclic and tricyclic cannabinoids
03/06/2012CA2446705C Compositions of quinoxaline-based therapeutic agents and fatty acids having enhanced pharmacokinetic characteristics
03/01/2012WO2012026614A1 Composition suppressing matrix-metalloproteinase activity
03/01/2012WO2012026609A1 Aqueous composition for ophthalmic administration
03/01/2012WO2011137228A3 Composition and method for treating eustachian tube dysfunction
03/01/2012US20120053242 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053176 Adenosine a3 receptor modulating compounds and methods of use thereof
03/01/2012US20120053175 Mlk inhibitors and methods of use
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 531